|
|
Article: Berkeley HeartLab, Inc. Gains Exclusive License to New Heart Disease Diagnostic Test Panel from Ernest Orlando Lawrence Berkeley National Laboratory; New Diagnostic Test Panel Identifies Key Risk Factors Cited by American College of Cardiology.
- Article from:
- Business Wire
- Article date:
- May 13, 1996
CopyrightCOPYRIGHT 1996 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SAN MATEO, Calif.--(BUSINESS WIRE)--May 13, 1996--Berkeley HeartLab, Inc., a company focusing on new diagnostic technology for detecting heart disease, announced today it has signed a $3.8 million, five-year research agreement with a technology option with Ernest Orlando Lawrence Berkeley National Laboratory (LBNL) to acquire exclusive worldwide rights to a new diagnostic technology that is a major improvement over existing cholesterol tests in measuring heart disease risk factors.
Cardiovascular disease is the nation's leading cause of death in the U.S., accounting for 35 to 40 percent of all deaths.
The proprietary screening technology is the foundation for a ...